SGLT2 Inhibitors Appear Protective in CKD, Kidney Transplantation
SGLT2 inhibitors are associated with an initial dip in eGFR, so nephrologists need to monitor kidney function.
SGLT2 inhibitors are associated with an initial dip in eGFR, so nephrologists need to monitor kidney function.
Obesity rates in glomerular disease have multiplied more than 10-fold over the last 40 years.
N-nitroso-irbesartan is a probable human carcinogen based on results from laboratory tests.
A large multinational study examined the potential impact of dapagliflozin on kidney disease in people with type 2 diabetes.
In FIDELITY, investigators pooled data from more than 13,000 patients from the FIDELIO-DKD and FIGARO-DKD trials.
More severe frailty predicted a higher risk of UTIs.
Researchers identified lipidomic predictors of rapid decline of kidney function in individuals with type 1 diabetes.
Dapagliflozin’s benefits among patients with stage 4 CKD were consistent with those observed in the larger DAPA-CKD cohort with stage 2-3 CKD.
Study findings indicate a correlation between iPTH and vascular calcification in patients with diabetic kidney disease.
The approval was based on data from the phase 3 FIDELIO-DKD trial.